WPP
Whalerock Point Partners Portfolio holdings
AUM
$463M
This Quarter Return
+2.89%
1 Year Return
+18.05%
3 Year Return
+96.01%
5 Year Return
+161.07%
10 Year Return
–
AUM
$242M
AUM Growth
–
Cap. Flow
+$242M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
50.25%
Holding
142
New
142
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Berkshire Hathaway Class A
BRK.A
|
$74.4M |
| 2 |
Apple
AAPL
|
$7.07M |
| 3 |
Johnson & Johnson
JNJ
|
$5.97M |
| 4 |
INNOVATE Corp
VATE
|
$5.89M |
| 5 |
Exxon Mobil
XOM
|
$5.22M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Financials | 40.35% |
| 2 | Healthcare | 13.76% |
| 3 | Industrials | 7.82% |
| 4 | Technology | 6.94% |
| 5 | Consumer Staples | 6.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Northrop Grumman
NOC
$84.5B
| $251K | 0.1% | +1,175 | New | +$251K |
|
127
IBM
IBM
$227B
| $236K | 0.1% | +1,488 | New | +$236K |
|
128
ConocoPhillips
COP
$124B
| $235K | 0.1% | +5,425 | New | +$235K |
|
129
Novartis
NVS
$245B
| $226K | 0.09% | +2,870 | New | +$226K |
|
130
iShares Core S&P 500 ETF
IVV
$662B
| $214K | 0.09% | +985 | New | +$214K |
|
131
Starbucks
SBUX
$100B
| $213K | 0.09% | +3,950 | New | +$213K |
|
132
iShares Core S&P Mid-Cap ETF
IJH
$100B
| $212K | 0.09% | +1,378 | New | +$212K |
|
|
PX
133
DELISTED
Praxair Inc
PX
| $211K | 0.09% | +1,750 | New | +$211K |
|
134
Invesco FTSE RAFI US 1000 ETF
PRF
$8.08B
| $210K | 0.09% | +2,253 | New | +$210K |
|
135
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.8B
| $208K | 0.09% | +3,875 | New | +$208K |
|
136
Abbott
ABT
$231B
| $207K | 0.09% | +4,906 | New | +$207K |
|
137
Trex
TREX
$6.61B
| $205K | 0.08% | +3,500 | New | +$205K |
|
138
LXP Industrial Trust
LXP
$2.69B
| $159K | 0.07% | +15,500 | New | +$159K |
|
|
VER
139
DELISTED
VEREIT, Inc.
VER
| $153K | 0.06% | +14,800 | New | +$153K |
|
140
Annaly Capital Management
NLY
$13.6B
| $123K | 0.05% | +11,765 | New | +$123K |
|
|
IMBI
141
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
| $106K | 0.04% | +46,500 | New | +$106K |
|
|
NWBO
142
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
| $8K | ﹤0.01% | +15,000 | New | +$8K |
|